(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswir...developer and provider of vaccines, announced toda...to establish Sinovac (Dalian) Vaccine,Technology C...evelop, produce,and commercialize human-use vaccin...rience in developing and commercializing world-cla...
(Date:11/25/2009)..., , SAN DIEGO, Nov. 25 /PRNewswire-FirstC...nnounced today that Barry D. Quart, Pharm.D., pres... the Piper Jaffray 21st Annual Health Care Confere...er Jaffray 21st Annual Health Care Conference,Date....m. Eastern Time,Location: The New York Palace Ho...
(Date:11/24/2009)..., , HOUSTON, Nov. 24 /PRNewswire-First...provider of electrical and communications systems ...sidential markets, announced today that its commer...om Manhattan Torcon JV to install the electrical s...acement facility at the U.S. Army Medical Research...
(Date:11/24/2009)... The New York investment ...td (ASX:NEU) has agreed an AU$6.7 mil convertible ...nvestor. The private placement was arranged by KTA... advisor. , New York (PRW...investment bank KTA Capital, LLC ("KTA Capita...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2...ections that keep a fly,s gaze stable during compl...ly to obstacles in its flight path, are revealed i...2008). , Scientists from Imperial College London...ts of nerve cells in a fly,s brain that help it pr... to its muscles. This helps it stay agile and resp...
...RNewswire-FirstCall/ - Lorus Therapeutics Inc.,(Lo...the research and,development of pharmaceutical pro...r, today reported financial results for the three ...fied otherwise, all amounts are in Canadian,dollar...cology studies for Lorus, lead anticancer small ...
...uly 21 Zenobia Therapeutics, Inc.,(Zenobia) annou...eir,facility in La Jolla, California. Zenobia was ...d into their new laboratory and office facilities,...as of high-throughput,structural biology and fragm...cus on limited population diseases that are,tradit...
Other Biology Technology:It takes nerves for flies to keep a level head 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 3Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 4Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 5Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 6Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 7Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 8Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company 2Chicken Anti-Human LYZL6 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-DcR1 Monoclonal Antibody, Phycoerythrin Conjugated, Clone DJR3 from Abcam
Beadlyte® Human IgE Standard from Upstate
DEPC water from Mo Bio Laboratories, Inc.
Biology Products: